Results 151 to 160 of about 36,891 (208)

Assess the reporting quality of randomized controlled clinical trials exploring the efficacy and safety of new anticoagulants versus warfarin in patients with atrial fibrillation based on CONCORT statement [PDF]

, 2016
Μαντζουράτου, Πολυξένη Δ.
core   +1 more source

Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers. [PDF]

Eur Heart J
Roy DC, Wang TF, Mallick R, Burger D, Carrier M, Wells P, Hawken S.   +6 more
europepmc   +1 more source

A multicenter prospective real-world cohort study of direct oral anticoagulant use for venous thromboembolism prophylaxis in nephrotic syndrome. [PDF]

BMC Nephrol
Meena P, Kumar N, Panda SK, Kandari S, Prasad GS, Bhargava V, Khandelia V, Malviya P, Rout NK, Das P, Garg A, Mylliemngap B, Kumari P.   +12 more
europepmc   +1 more source

Asundexian Versus Apixaban in Patients With Atrial Fibrillation. [PDF]

Health Sci Rep
Saeed Z, Zehra SA, Tariq S, Zumaran RP, Kotte M, Hameed Z, Joshi N, Kumari P, Kumari K, Habib A, Talat F, Taj O, Malik J, Perveen A.   +13 more
europepmc   +1 more source

Safety and Efficacy of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Cerebrovascular Ischemic Outcomes in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis. [PDF]

Clin Cardiol
Nasir A, Anwar N, Kamran AB, Muhammad A, Haider A, Mubashar M, Tariq F, Helou M, Shami B.   +8 more
europepmc   +1 more source

The comparison of inflammation markers in patients with non-valvular atrial fibrillation using warfarin and switched to apixaban. [PDF]

Pak J Med Sci
Duman OO, Alpaslan E.
europepmc   +1 more source

Anticoagulation Therapy in Advanced Chronic Kidney Disease: Balancing Bleeding and Thromboembolic Risk. [PDF]

Int J Mol Sci
Suliman IL, Tuta LA, Pana C, Panculescu FG, Alexandru A, Fasie D, Cimpineanu B, Popescu S, Enache FD, Nitu RA, Chisnoiu T, Popa MF, Tudor IC, Mihai ML, Deacu S, Cozaru GC, Bordeianu I.   +16 more
europepmc   +1 more source

Changes in the use of vitamin K antagonists and direct oral anticoagulants and impact on the incidence of oral anticoagulation-related intracerebral hemorrhage: population-wide prescription patterns in two 5-year cohorts. [PDF]

Ann Med
Tomppo L, Sallinen H, Lankinen O, Mastoras G, Georgiopoulos G, Poli S, Putaala J, Strbian D.   +7 more
europepmc   +1 more source

Tightening Our Belts in the New Healthcare Economy [PDF]

, 2013
Pizzi, Laura, PharmD,MPH
core   +1 more source

Comparing Efficacy and Safety of Different Anticoagulants in Cerebral Venous Thrombosis: A Systematic Review and Network Meta-Analysis. [PDF]

Clin Appl Thromb Hemost
Waseem MH, Abideen ZU, Rissardo JP, Khan MH, Farhan K, Fornari Caprara AL, Thada PK, Dmytriw AA.   +7 more
europepmc   +1 more source